Sutro Biopharma, Inc. STRO

15.98 0.27 1.72% as of 25 Sep
Market cap
$260.5M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
141.43 316.90 375.62 334.36 197.94 368.14 117.86 204.49 22.02 47.52
Receivables
3.98 8.62 36.08 7.12 12.45 5.56 6.30 2.49 1.62 0.58
Total current assets
150.93 343.31 421.54 353.15 218.52 378.18 128.57 209.95 25.63 49.69
Property, Plant, Equpment (Net)
10.65 18.19 21.94 24.62 22.55 12.94 9.63 10.93 14.00 18.69
Long-Term Investments
— — — — 68.78 0.87 15.61 0.02 0.02 0.28
Long-term assets (Other)
1.35 8.03 4.44 2.73 2.53 2.99 2.56 2.26 1.14 0.90
Total non-current assets
22.90 43.90 49.19 53.79 122.89 15.93 27.80 13.19 15.14 19.59
Total Assets
173.83 387.21 470.74 406.94 341.41 394.11 156.37 223.14 40.77 69.28
Accounts Payable
7.57 10.48 9.44 4.80 6.01 5.54 5.58 3.06 2.90 3.39
Accrued Expenses
49.22 44.16 53.16 27.91 19.82 8.82 6.02 6.22 3.64 3.19
Current Part of Debt
— — 4.06 12.50 9.38 — 1.00 4.72 14.56 —
Current Revenue (Deferred)
10.56 69.78 20.67 16.76 5.50 14.60 19.47 21.57 10.71 43.58
Other current liabilities
— — — 44.67 20.00 0.63 0.90 0.85 0.14 0.02
Total current liabilities
75.13 131.89 93.75 66.55 41.74 29.60 32.97 36.42 31.96 50.18
Long Term Debt (Total)
— — — 3.77 15.74 24.55 8.88 10.00 — 1.19
Non-current Revenue (Deferred)
2.03 12.54 53.38 89.89 0.00 7.44 16.60 45.08 13.59 6.20
Minority Interests
— — — — — — — — 1.71 1.19
Non-current Liabilities (Other)
221.23 182.50 150.81 0.12 0.15 0.48 0.13 0.10 0.01 0.10
Total non-current liabilities
231.15 210.71 227.34 123.35 47.11 32.47 25.61 55.18 15.31 7.49
Total liabilities
306.28 342.61 321.09 189.90 88.84 62.06 58.58 91.60 47.27 57.67
Additional Paid In Capital
845.48 831.42 708.98 670.22 586.24 559.75 293.35 281.89 6.22 4.65
Preferred Stock (Total)
— — — — — — 293.35 281.89 102.51 102.51
Common Stock (Net)
0.01 0.01 0.06 0.06 0.05 0.05 0.02 0.02 — —
Retained Earnings
(977.95) (786.87) (559.41) (452.61) (333.41) (227.87) (195.74) (150.33) (115.01) (95.32)
Shareholders Equity (Other)
— — — — — — — 0.00 (0.21) (0.21)
Common Equity (Total)
(132.45) 44.60 149.65 217.05 252.56 332.05 97.79 131.54 (109.00) (90.88)
Shareholders Equity (Total)
(132.45) 44.60 149.65 217.05 252.56 332.05 97.79 131.54 (6.50) 11.62
Shareholders Equity and Liabilities (Total)
173.83 387.21 470.74 406.94 341.41 394.11 156.37 223.14 40.77 69.28
Shares (Common)
8.58 8.31 6.10 5.75 4.63 4.58 2.31 2.28 0.05 0.05
Shares (Preferred)
— — — — — — — — 17.38 17.38
Shareholders Equity (Tangible)
(132.45) 44.60 149.65 217.05 252.56 332.05 97.79 131.54 (6.50) 11.60
Net Debt
(141.43) (316.89) (371.56) (318.09) (172.82) (343.59) (107.99) (189.77) (7.46) (46.33)
Total Debt
— — 4.06 16.27 25.11 24.55 9.88 14.72 14.56 1.19

Fold the line items

In millions of $ except per-share values · columns are period end dates